AU2007257922A1 - Novel MCH receptor antagonists - Google Patents
Novel MCH receptor antagonists Download PDFInfo
- Publication number
- AU2007257922A1 AU2007257922A1 AU2007257922A AU2007257922A AU2007257922A1 AU 2007257922 A1 AU2007257922 A1 AU 2007257922A1 AU 2007257922 A AU2007257922 A AU 2007257922A AU 2007257922 A AU2007257922 A AU 2007257922A AU 2007257922 A1 AU2007257922 A1 AU 2007257922A1
- Authority
- AU
- Australia
- Prior art keywords
- phenyl
- methoxy
- chloro
- thieno
- pyridin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US81184106P | 2006-06-08 | 2006-06-08 | |
| US60/811,841 | 2006-06-08 | ||
| PCT/US2007/070662 WO2007146758A2 (en) | 2006-06-08 | 2007-06-08 | Novel mch receptor antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2007257922A1 true AU2007257922A1 (en) | 2007-12-21 |
Family
ID=38651254
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2007257922A Abandoned AU2007257922A1 (en) | 2006-06-08 | 2007-06-08 | Novel MCH receptor antagonists |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US8263772B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2029609A2 (cg-RX-API-DMAC7.html) |
| JP (1) | JP5198439B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN101454328A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2007257922A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BRPI0712680A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2652385A1 (cg-RX-API-DMAC7.html) |
| EA (1) | EA015127B1 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2008015662A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2007146758A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102264737A (zh) * | 2008-12-23 | 2011-11-30 | 雅培制药有限公司 | 抗病毒化合物 |
| RU2505539C2 (ru) | 2008-12-23 | 2014-01-27 | Эбботт Лэборетриз | Антивирусные соединения |
| BRPI0923527A2 (pt) | 2008-12-24 | 2016-08-09 | Syngenta Ltd | métodos de preparo de fungicidas |
| WO2010120935A1 (en) * | 2009-04-15 | 2010-10-21 | Abbott Laboratories | Anti-viral compounds |
| US9394279B2 (en) | 2009-06-11 | 2016-07-19 | Abbvie Inc. | Anti-viral compounds |
| US8937150B2 (en) | 2009-06-11 | 2015-01-20 | Abbvie Inc. | Anti-viral compounds |
| US8716454B2 (en) | 2009-06-11 | 2014-05-06 | Abbvie Inc. | Solid compositions |
| EP2853531A3 (en) * | 2009-06-11 | 2015-08-12 | AbbVie Bahamas Ltd. | Antiviral compounds |
| NZ605440A (en) | 2010-06-10 | 2014-05-30 | Abbvie Bahamas Ltd | Solid compositions comprising an hcv inhibitor |
| US10201584B1 (en) | 2011-05-17 | 2019-02-12 | Abbvie Inc. | Compositions and methods for treating HCV |
| US9034832B2 (en) | 2011-12-29 | 2015-05-19 | Abbvie Inc. | Solid compositions |
| US20150065343A1 (en) | 2012-04-02 | 2015-03-05 | Basf Se | Acrylamide compounds for combating invertebrate pests |
| BR112014027133A2 (pt) | 2012-05-09 | 2017-06-27 | Basf Se | compostos, composição agrícola ou veterinária, método para o controle das pragas de invertebrados, material de propagação dos vegetais e método para o tratamento ou proteção de um animal. |
| PT2970205T (pt) | 2013-03-14 | 2019-08-26 | Tolero Pharmaceuticals Inc | Inibidores da jak2 e da alk2 e métodos para a sua utilização |
| US11484534B2 (en) | 2013-03-14 | 2022-11-01 | Abbvie Inc. | Methods for treating HCV |
| WO2015103490A1 (en) | 2014-01-03 | 2015-07-09 | Abbvie, Inc. | Solid antiviral dosage forms |
| AR102849A1 (es) * | 2015-03-09 | 2017-03-29 | Astellas Pharma Inc | Compuesto de piridina bicíclica |
| PE20180572A1 (es) | 2015-06-18 | 2018-04-04 | Cephalon Inc | Derivados de piperidina 1,4-sustituidos |
| EP3310773B1 (en) | 2015-06-18 | 2020-12-02 | 89Bio Ltd. | Substituted 4-benzyl and 4-benzoyl piperidine derivatives |
| KR20210038906A (ko) | 2018-07-26 | 2021-04-08 | 스미토모 다이니폰 파마 온콜로지, 인크. | 비정상적 acvr1 발현과 연관된 질환을 치료하는 방법 및 그에 사용하기 위한 acvr1 억제제 |
| EP3873474A4 (en) | 2018-10-30 | 2022-07-13 | Nuvation Bio Inc. | HETEROCYCLIC COMPOUNDS USED AS BET INHIBITORS |
| JP7465945B2 (ja) * | 2019-07-02 | 2024-04-11 | ニューベイション・バイオ・インコーポレイテッド | Bet阻害剤としてのヘテロ環式化合物 |
| WO2024020034A1 (en) * | 2022-07-20 | 2024-01-25 | Arcus Biosciences, Inc. | Cbl-b inhibitors and methods of use thereof |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002003370A (ja) * | 1999-09-20 | 2002-01-09 | Takeda Chem Ind Ltd | メラニン凝集ホルモン拮抗剤 |
| US20020099073A1 (en) * | 2000-07-07 | 2002-07-25 | Andersen Henrik Sune | Modulators of protein tyrosine phosphatases (PTPases) |
| GB0124627D0 (en) * | 2001-10-15 | 2001-12-05 | Smithkline Beecham Plc | Novel compounds |
| US20060194871A1 (en) * | 2003-04-11 | 2006-08-31 | Barvian Kevin K | Heterocyclic mchr1 antagoists |
| JP2007509158A (ja) * | 2003-10-23 | 2007-04-12 | グラクソ グループ リミテッド | 肥満、糖尿病、うつ病及び不安を治療するためのmchr1アンタゴニストとしての3−(4−アミノフェニル)チエノピリミド−4−オン誘導体 |
| WO2005047293A1 (en) | 2003-11-07 | 2005-05-26 | Neurocrine Biosciences, Inc. | Melanin-concentrating hormone receptor antagonists and compositions and methods related thereto |
| BRPI0507629A (pt) * | 2004-02-13 | 2007-07-03 | Banyu Pharma Co Ltd | composto, antagonista do receptor e agonista inverso do receptor da histamina h3, agente profilático ou terapêutico para uma doença metabólica, uma doença circulatória ou uma doença do sistema nervoso, ou um seu sal farmaceuticamente aceitável |
| US20050256124A1 (en) * | 2004-04-15 | 2005-11-17 | Neurocrine Biosciences, Inc. | Melanin-concentrating hormone receptor antagonists and compositions and methods related thereto |
| BRPI0512252A (pt) | 2004-06-18 | 2008-02-19 | Biolipox Ab | composto ou um sal farmaceuticamente aceitável do mesmo, formulação farmacêutica, uso de um composto, método de tratamento de uma doença, produto combinado, e, processo para a preparação de um composto |
| ATE446962T1 (de) * | 2004-12-17 | 2009-11-15 | Lilly Co Eli | Thiazolopyridinon-derivate als mch- rezeptorantagonisten |
| CA2636617A1 (en) * | 2006-02-15 | 2007-08-23 | Lothar Schwink | Novel aminoalcohol-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments |
| RU2008136898A (ru) * | 2006-02-15 | 2010-03-20 | Санофи-Авентис (Fr) | Азациклил-замещенные арилдигидроизохинолиноны, способ их получения и их применение в качестве лекарственных средств |
-
2007
- 2007-06-08 CA CA002652385A patent/CA2652385A1/en not_active Abandoned
- 2007-06-08 CN CNA2007800195489A patent/CN101454328A/zh active Pending
- 2007-06-08 AU AU2007257922A patent/AU2007257922A1/en not_active Abandoned
- 2007-06-08 BR BRPI0712680-8A patent/BRPI0712680A2/pt not_active IP Right Cessation
- 2007-06-08 WO PCT/US2007/070662 patent/WO2007146758A2/en not_active Ceased
- 2007-06-08 MX MX2008015662A patent/MX2008015662A/es unknown
- 2007-06-08 JP JP2009514544A patent/JP5198439B2/ja not_active Expired - Fee Related
- 2007-06-08 EA EA200870517A patent/EA015127B1/ru not_active IP Right Cessation
- 2007-06-08 US US12/298,792 patent/US8263772B2/en not_active Expired - Fee Related
- 2007-06-08 EP EP07798258A patent/EP2029609A2/en not_active Withdrawn
-
2012
- 2012-08-08 US US13/569,899 patent/US20120302547A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2007146758A3 (en) | 2008-02-07 |
| US8263772B2 (en) | 2012-09-11 |
| JP5198439B2 (ja) | 2013-05-15 |
| US20090093456A1 (en) | 2009-04-09 |
| EA200870517A1 (ru) | 2009-04-28 |
| CA2652385A1 (en) | 2007-12-21 |
| BRPI0712680A2 (pt) | 2012-11-20 |
| WO2007146758A2 (en) | 2007-12-21 |
| US20120302547A1 (en) | 2012-11-29 |
| EA015127B1 (ru) | 2011-06-30 |
| JP2009539875A (ja) | 2009-11-19 |
| CN101454328A (zh) | 2009-06-10 |
| EP2029609A2 (en) | 2009-03-04 |
| MX2008015662A (es) | 2009-01-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8263772B2 (en) | MCH receptor antagonists | |
| AU2005316314B2 (en) | Thiazolopyridinone derivates as MCH receptor antagonists | |
| AU2009251083B2 (en) | Thienopyridine and furopyridine kinase inhibitors | |
| CN121568930A (zh) | 化合物及其作为抗癌药的用途 | |
| US7781431B2 (en) | Thienopyrroles as antiviral agents | |
| CZ2004498A3 (cs) | Pyrimidinonové deriváty, způsob výroby a farmaceutický prostředek | |
| US20090264411A1 (en) | Fused thiophene derivatives as mek inhibitors | |
| AU2007334171A1 (en) | 5- [4- (azetidin-3-yloxy) -phenyl] -2-phenyl-5H-thiazolo [5,4-c] pyridin-4-one derivatives and their use as MCH receptor antagonists | |
| JP2004509893A (ja) | 置換型アゼピノ[4,5b]インドリン誘導体 | |
| CA2536107A1 (en) | Substituted piperazines of azepines, oxazepines, and thiazepines | |
| NZ549386A (en) | (Indol-3-yl)-heterocycle derivatives as agonists of the cannabinoid CB1 receptor | |
| US8101764B2 (en) | MCH receptor antagonists | |
| US7285557B2 (en) | Pyrimidinones as melanin concentrating hormone receptor 1 | |
| KR20050024358A (ko) | 비만증, 타입 ⅱ 당뇨병 및 cns 장애의 치료에 유용한신규 화합물 | |
| AU2002335004A1 (en) | Pyrimidinones as melanin concentrating hormone receptor 1 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK4 | Application lapsed section 142(2)(d) - no continuation fee paid for the application |